NCT04256499

Brief Summary

Acute water load test has been using to diagnose renal ability to excrete water for decades. Latest recommendations for the diagnosis of hyponatremia do not recommend performing such a test. The investigators aim at, retrospectively, study the value of acute water load test in patients suffering from a syndrome of inappropriate antidiuresis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2001

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2001

Completed
19 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 3, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
Last Updated

February 5, 2020

Status Verified

February 1, 2020

Enrollment Period

19 years

First QC Date

February 3, 2020

Last Update Submit

February 4, 2020

Conditions

Keywords

hyponatremiaSIADwater load test

Outcome Measures

Primary Outcomes (1)

  • Natremia

    Plasma sodium concentration (abnormal if \<135mM)

    any time after water load test from hour 2 to hour 6

Secondary Outcomes (3)

  • Plasma osmolality

    any time after water load test from hour 2 to hour 6

  • Excretion of water load

    after water load test from hour 0 to hour 6

  • Urine osmolality

    any time after water load test from hour 2 to hour 6

Other Outcomes (1)

  • Body weight

    Value at hour 6 versus initial value (hour 0)

Study Arms (2)

Water load test

Patients experiencing a syndrome of inappropriate antidiuresis who had an acute water load test

Procedure: Acute water load test

Control group

Patients who had an acute water load test and who did not experience any water homeostasis anomalies

Procedure: Acute water load test

Interventions

The acute water load test consists in administering orally 20 mL/kg (of body weight) of water (ingested in less than 30 min) and then follow (during 4 to 6 hours) blood and urine parameters.

Control groupWater load test

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In this retrospective study, the included population is composed only with adult patients experiencing a syndrome of inappropriate antidiuresis (SIAD) who were explored by an acute water load test at the Renal and Metabolic Diseases Unit of the European George Pompidou Hospital, Paris, France.

You may qualify if:

  • ≥ 18 years old at the time of the test
  • affiliated to a social insurance system
  • water load test performed at the Renal and Metabolic Diseases Unit of the European George Pompidou Hospital, AP-HP, Paris, France
  • between 01/01/2001 and 12/31/2019

You may not qualify if:

  • hypernatremia and/or polyuria-polydipsia (diabetes insipidus)
  • hyponatremia due to a tea and toast syndrome and/or a beer potomania
  • hyponatremia due to a high (or normal) osmolality related to diabetes mellitus, hyperproteinemia and/or intoxication
  • chronic kidney disease with an estimated glomerular filtration rate (eGFR) by the MDRD formula \<60 mL/min/1.73m2
  • hyponatremia related to thiazides
  • hyponatremia related to an hypovolemic status
  • syndrome of inappropriate antidiuresis related to an endocrine disorder (such as hypothyroidism or adrenal insufficiency)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

European Georges Pompidou Hospital, APHP

Paris, 75908, France

Location

MeSH Terms

Conditions

Inappropriate ADH SyndromeHyponatremia

Condition Hierarchy (Ancestors)

Pituitary DiseasesHypothalamic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesWater-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Jean-Philippe Bertocchio, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 3, 2020

First Posted

February 5, 2020

Study Start

January 1, 2001

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

February 5, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations